Richard Gralla, MD, Medical Director, Quality of Life Research Associates, New York City, discusses efforts that have been made to control chemotherapy-induced nausea and vomiting (CINV) while stressing that more advances have been developed that control emesis than nausea.

Progress has been made at managing both nausea and vomiting; however, it has become clear that the two are separate entities. Going back to the basics, textbooks suggest that the symptoms are anorexia, nausea, and vomiting, in that order. These symptoms may share pathways but each appears to have its own individual mechanism as well.

Gralla suggests that inhibiting fewer pathways such as neurokinin 1 (NK1) and serotonin, may help with vomiting or nausea but is not enough. Other pathways may be implicated and still need to be discovered and investigated in trials focusing specifically on nausea.

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Supportive Care

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Multinational Association of Supportive Care in Cancer International Symposium

Dr. Richard Gralla, from the Quality of Life Research Associates, on Chemotherapy-Induced Nausea and Vomiting.


Dr. Gralla on Chemotherapy-Induced Nausea and Vomiting